Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

74 ta ish

Ish: Resveratrol in oral cancer: a systematic review of preclinical studies on its anticancer mechanisms and therapeutic potential

  1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

    Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt +23

    Maqola202155 iqtibos
    ABI

  2. SYRCLE’s risk of bias tool for animal studies

    Carlijn R. Hooijmans, Maroeska M. Rovers, Rob BM de Vries +3

    Maqola20144 iqtibos
    ABI

  3. Autophagy and autophagy-related proteins in cancer

    Xiaohua Li, Shikun He, Binyun Ma

    Sharh maqola20204 iqtibos
    ABI

  4. Resveratrol (3,5,4′-trihydroxystilbene) and its properties in oral diseases

    D. Perrone, Maria Pia Fuggetta, Fatima Ardito +5

    Maqola20173 iqtibos
    ABI

  5. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges

    Chin-Yap Loh, Jian Chai, Ting Tang +5

    Sharh maqola20193 iqtibos
    ABI

  6. Resveratrol for cancer therapy: Challenges and future perspectives

    Boxu Ren, Marabeth Xin-Yi Kwah, Cuiliu Liu +8

    Sharh maqola20213 iqtibos
    ABI

  7. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment

    Sahar Mafi, Behzad Mansoori, Shahram Taeb +4

    Sharh maqola20222 iqtibos
    ABI

  8. Chemotherapy-Induced Tissue Injury: An Insight into the Role of Extracellular Vesicles-Mediated Oxidative Stress Responses

    Chontida Yarana, Daret St. Clair

    Sharh maqola20172 iqtibos
    ABI

  9. Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages

    Rajalaxmi Pradhan, Subhajit Chatterjee, Krushna Chandra Hembram +3

    Maqola20212 iqtibos
    ABI

  10. Inflammation and tumor progression: signaling pathways and targeted intervention

    Huakan Zhao, Lei Wu, Guifang Yan +4

    Maqola20212 iqtibos
    ABI

  11. Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review

    Teklie Mengie Ayele, Zelalem Tilahun Muche, Awgichew Behaile Teklemariam +2

    Sharh maqola20222 iqtibos
    ABI

  12. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy

    Shanna Qian, Zhong Wei, Wanting Yang +3

    Sharh maqola20222 iqtibos
    ABI

  13. Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway

    Rajalaxmi Pradhan, Subarno Paul, Biswajit Das +4

    Maqola20222 iqtibos
    ABI

  14. Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment

    Aranka Brockmueller, Sosmitha Girisa, Ajaikumar B. Kunnumakkara +1

    Maqola20232 iqtibos
    ABI

  15. Regulation of the Notch signaling pathway by natural products for cancer therapy

    Jiayi Cai, Yajie Qiao, Lingbin Chen +2

    Sharh maqola20232 iqtibos
    ABI

  16. Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions

    Lolita Kuršvietienė, Dalia M. Kopustinskienė, Inga Stanevičienė +4

    Maqola20232 iqtibos
    ABI

  17. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

    Yamei Hu, Zigang Dong, Kangdong Liu

    Maqola20242 iqtibos
    ABI

  18. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons

    Seyed Aria Nejadghaderi, Maryam Balibegloo, Nima Rezaei

    Maqola20242 iqtibos
    ABI

  19. The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens

    Eduarda Ribeiro, Nuno Vale

    Maqola20242 iqtibos
    ABI

  20. Oral cancer: Recent breakthroughs in pathology and therapeutic approaches

    Surekha Ramachandran

    Maqola20242 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI